关注
Batoul Farran
Batoul Farran
Henry Ford Health
在 hfhs.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
An update on the physiological and therapeutic relevance of GPCR oligomers
B Farran
Pharmacological research 117, 303-327, 2017
1152017
Folate-conjugated nanovehicles: Strategies for cancer therapy
B Farran, RC Montenegro, P Kasa, E Pavitra, YS Huh, YK Han, MA Kamal, ...
Materials Science and Engineering: C 107, 110341, 2020
792020
Reactive oxygen species (ROS): Critical roles in breast tumor microenvironment
RR Malla, N Surepalli, B Farran, SV Malhotra, GP Nagaraju
Critical Reviews in Oncology/Hematology 160, 103285, 2021
472021
Nanoparticles guided drug delivery and imaging in gastric cancer
GP Nagaraju, G Srivani, B Dariya, G Chalikonda, B Farran, SK Behera, ...
Seminars in Cancer Biology 69, 69-76, 2021
452021
Horizons of nanotechnology applications in female specific cancers
B Rajitha, RR Malla, R Vadde, P Kasa, GLV Prasad, B Farran, S Kumari, ...
Seminars in cancer biology 69, 376-390, 2021
432021
Molecular docking studies of angiogenesis target protein HIF-1α and genistein in breast cancer
V Mukund, MS Saddala, B Farran, M Mannavarapu, A Alam, GP Nagaraju
Gene 701, 169-172, 2019
412019
The dynamic interactions between the stroma, pancreatic stellate cells and pancreatic tumor development: Novel therapeutic targets
B Farran, GP Nagaraju
Cytokine & growth factor reviews 48, 11-23, 2019
392019
Folate-targeted immunotherapies: Passive and active strategies for cancer
B Farran, E Pavitra, P Kasa, S Peela, GSR Raju, GP Nagaraju
Cytokine & growth factor reviews 45, 45-52, 2019
392019
Gastric cancer management: kinases as a target therapy
B Farran, S Müller, RC Montenegro
Clinical and Experimental Pharmacology and Physiology 44 (6), 613-622, 2017
362017
Nanoparticles mediated tumor microenvironment modulation: current advances and applications
GSR Raju, E Pavitra, GL Varaprasad, SS Bandaru, GP Nagaraju, ...
Journal of Nanobiotechnology 20 (1), 274, 2022
332022
Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib
RC Montenegro, A Howarth, A Ceroni, V Fedele, B Farran, FP Mesquita, ...
Oncotarget 11 (5), 535, 2020
312020
Small molecule tyrosine kinase inhibitors and pancreatic cancer—Trials and troubles
BVKS Lakkakula, B Farran, S Lakkakula, S Peela, NS Yarla, ...
Seminars in cancer biology 56, 149-167, 2019
282019
A study of circulating microRNAs identifies a new potential biomarker panel to distinguish aggressive prostate cancer
B Farran, G Dyson, D Craig, A Dombkowski, JL Beebe-Dimmer, IJ Powell, ...
Carcinogenesis 39 (4), 556-561, 2018
282018
Convalescent plasma transfusion a promising therapy for coronavirus diseases 2019 (COVID-19): current updates
HK Verma, B Farran, LVKS Bhaskar
Antibody Therapeutics 3 (2), 115-125, 2020
242020
Napabucasin (BBI 608), a potent chemoradiosensitizer in rectal cancer
GP Nagaraju, B Farran, M Farren, G Chalikonda, C Wu, GB Lesinski, ...
Cancer 126 (14), 3360-3371, 2020
212020
Mitochondrial-targeted nanoparticles: Delivery and therapeutic agents in cancer
C Ganji, V Muppala, M Khan, GP Nagaraju, B Farran
Drug Discovery Today 28 (3), 103469, 2023
172023
Aquaporins in female specific cancers
P Kasa, B Farran, GLV Prasad, GP Nagaraju
Gene 700, 60-64, 2019
132019
Understanding the molecular mechanisms that regulate pancreatic cancer stem cell formation, stemness and chemoresistance: a brief overview
GP Nagaraju, B Farran, T Luong, BF El-Rayes
Seminars in Cancer Biology 88, 67-80, 2023
102023
Computational analysis of nuclear factor-κB and resveratrol in colorectal cancer
B Dariya, SK Behera, G Srivani, B Farran, A Alam, GP Nagaraju
Journal of Biomolecular Structure and Dynamics 39 (8), 2914-2922, 2021
102021
The extrema of circulating miR-17 are identified as biomarkers for aggressive prostate cancer
G Dyson, B Farran, S Bolton, DB Craig, A Dombkowski, JL Beebe-Dimmer, ...
American Journal of Cancer Research 8 (10), 2088, 2018
102018
系统目前无法执行此操作,请稍后再试。
文章 1–20